Safety, Tolerability, Pharmacokinetics & Pharmacodynamics Study of Ropeginterferon Alfa-2b in Healthy Japanese and Caucasian Subjects
Clinical trial NCT03546465 · COMPLETED
Trial details
- NCT number
- NCT03546465
- Sponsor
- PharmaEssentia Japan K.K.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-07
- Primary completion
- 2019-07-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.